Characteristics, incidence, and risk factors of immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer-Reference-Cited by-同舟云学术

Characteristics, incidence, and risk factors of immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer

Published:2018-11 Issue: Volume:125 Page:150-156
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Cho Jun Yeun,Kim Junghoon,Lee Jong Seok,Kim Yu Jung,Kim Se Hyun,Lee Yeon Joo,Cho Young-Jae^ORCID,Yoon Ho Il,Lee Jae Ho,Lee Choon-Taek^ORCID,Park Jong Sun

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference22 articles.

1. Temporal trends in small cell lung cancer: analysis of the national surveillance, epidemiology, and end-results (SEER) database;Navada;J. Clin. Oncol.,2006

2. Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer;Antonia;N. Engl. J. Med.,2017

3. Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non–small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study;Lynch;J. Clin. Oncol.,2012

4. Treatment of the immune-related adverse effects of immune checkpoint inhibitors: a review;Friedman;JAMA Oncol.,2016

5. Nivolumab versus docetaxel in advanced nonsquamous non–small-cell lung cancer;Borghaei;N. Engl. J. Med.,2015

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating risk factors and treatment options for severe, partially steroid responsive, and steroid-refractory checkpoint inhibitor pneumonitis;The Oncologist;2024-06-17

2. Drug-induced Lung Disease in the Oncology Patient;Clinics in Chest Medicine;2024-06

3. Risk factors of immune checkpoint inhibitor-related pneumonitis after neoadjuvant immunochemotherapy for resectable NSCLC;BMC Pulmonary Medicine;2024-05-23

4. The relative risk of immune checkpoint inhibitor pneumonitis in advanced non-small- cell lung cancer: Meta-analyses of controlled clinical trials;PLOS ONE;2024-04-29

5. Bootstrap-quantile ridge estimator for linear regression with applications;PLOS ONE;2024-04-29